Gassert Chad 4

What Happened

• Chad Gassert, SVP - Corporate Development & Strategy at ANI Pharmaceuticals (ANIP), had 4,269 shares withheld on Feb 11, 2026 to satisfy tax withholding related to the vesting of performance stock units. The withheld shares were valued at $76.25 each, totaling roughly $325,511. This is a tax-withholding/settlement event (F), not an open-market sale.

Key Details

• Transaction date: 2026-02-11; filing date: 2026-02-13 (timely)
• Shares withheld/disposed: 4,269 at $76.25 per share; total value ≈ $325,511
• Reason: Shares withheld to cover taxes on vesting of 11,578 performance stock units (grant previously reported April 6, 2023) — exempt under Rule 16b-3 (footnote F1)
• Additional note: Reporting person holds voting and dispositive power over shares held by Chali Properties LLC (footnote F2)
• Shares owned after the transaction: not specified in the provided filing excerpt

Context

• This was a routine tax-withholding (share surrender) tied to the vesting of performance units, effectively a disposition for reporting purposes but typically administrative rather than a signal of insider sentiment. Rule 16b-3 exemption means the withholding was part of a company-approved settlement of vested awards.